High-dose contrast agent administration during complex coronary angioplasty

Area of Science:

• Cardiology
• Nephrology
• Radiology

Background:

• High-dose contrast media administration is sometimes necessary during complex coronary angioplasty.
• The potential for contrast-induced nephrotoxicity is a significant concern, particularly in vulnerable patient populations.

Purpose of the Study:

• To evaluate the necessity and outcomes of high-dose contrast media usage in coronary angioplasty.
• To assess the incidence of renal dysfunction following high-dose contrast administration.

Main Methods:

• Retrospective review of 730 consecutive patients undergoing coronary angioplasty over six months.
• Detailed analysis of 54 patients (7%) who received contrast doses >= 400 ml.
• Comparison of pre- and post-procedure serum creatinine levels.

Main Results:

• The mean contrast dose in the high-dose group was 496 ml.
• Serum creatinine increase >= 0.5 mg/dl occurred in 11% of patients, with 2% experiencing an increase >= 1.0 mg/dl.
• Factors contributing to high contrast doses included multilesion/multivessel angioplasty, prior bypass surgery, and combined procedures.
• Renal dysfunction was more common in patients with diabetes mellitus or baseline renal insufficiency.

Conclusions:

• High-dose contrast administration during complex coronary angioplasty is infrequently associated with significant nephrotoxicity.
• Patients with diabetes mellitus and/or baseline renal insufficiency are at higher risk for contrast-induced renal dysfunction.
• Minimizing contrast media doses should be prioritized in these at-risk patients whenever feasible.